GB9810181D0 - Novel formulations - Google Patents
Novel formulationsInfo
- Publication number
- GB9810181D0 GB9810181D0 GBGB9810181.9A GB9810181A GB9810181D0 GB 9810181 D0 GB9810181 D0 GB 9810181D0 GB 9810181 A GB9810181 A GB 9810181A GB 9810181 D0 GB9810181 D0 GB 9810181D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel formulations
- formulations
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810181.9A GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
IDW20002347A ID28019A (en) | 1998-05-13 | 1999-05-13 | A NEW FORMULATION THAT CONTAINS PAROXOXINE |
KR1020007012706A KR20010043574A (en) | 1998-05-13 | 1999-05-13 | Novel Formulation Containing Paroxetine |
EP99922302A EP1077682A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
JP2000547965A JP2002514591A (en) | 1998-05-13 | 1999-05-13 | Formulations containing new paroxetine |
PCT/GB1999/001520 WO1999058113A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
SK1714-2000A SK17142000A3 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
CN99808325A CN1308521A (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
HU0102064A HUP0102064A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine and process for its preparation |
PL99344573A PL344573A1 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
TR2000/03350T TR200003350T2 (en) | 1998-05-13 | 1999-05-13 | New formulation containing paroxetine. |
EA200001174A EA200001174A1 (en) | 1998-05-13 | 1999-05-13 | NEW READY PREPARATORY FORM CONTAINING PAROXETIN |
APAP/P/2000/002019A AP2000002019A0 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine. |
CA002331871A CA2331871A1 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
IL13959499A IL139594A0 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
AU39409/99A AU3940999A (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
BR9910401-6A BR9910401A (en) | 1998-05-13 | 1999-05-13 | New formulation containing paroxetine |
NO20005683A NO20005683L (en) | 1998-05-13 | 2000-11-10 | New formulation containing paroxetine |
ZA200006562A ZA200006562B (en) | 1998-05-13 | 2000-11-13 | Novel formulation containing paroxetine. |
BG105010A BG105010A (en) | 1998-05-13 | 2000-11-30 | Medicamentous form containing paroxetine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810181.9A GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9810181D0 true GB9810181D0 (en) | 1998-07-08 |
Family
ID=10831927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9810181.9A Ceased GB9810181D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulations |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1077682A2 (en) |
JP (1) | JP2002514591A (en) |
KR (1) | KR20010043574A (en) |
CN (1) | CN1308521A (en) |
AP (1) | AP2000002019A0 (en) |
AU (1) | AU3940999A (en) |
BG (1) | BG105010A (en) |
BR (1) | BR9910401A (en) |
CA (1) | CA2331871A1 (en) |
EA (1) | EA200001174A1 (en) |
GB (1) | GB9810181D0 (en) |
HU (1) | HUP0102064A2 (en) |
ID (1) | ID28019A (en) |
IL (1) | IL139594A0 (en) |
NO (1) | NO20005683L (en) |
PL (1) | PL344573A1 (en) |
SK (1) | SK17142000A3 (en) |
TR (1) | TR200003350T2 (en) |
WO (1) | WO1999058113A2 (en) |
ZA (1) | ZA200006562B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
AU2002330771A1 (en) * | 2001-10-22 | 2003-06-10 | Synthon B.V. | N-formyl derivatives of paroxetine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
EA002034B1 (en) * | 1997-01-15 | 2001-12-24 | Смитклайн Бичам Плс | Paroxetine compositions |
KR100775154B1 (en) * | 1997-12-19 | 2007-11-12 | 스미스클라인 비참 코포레이션 | Process for Manufacturing Bite-Dispersion Tablets |
-
1998
- 1998-05-13 GB GBGB9810181.9A patent/GB9810181D0/en not_active Ceased
-
1999
- 1999-05-13 CA CA002331871A patent/CA2331871A1/en not_active Abandoned
- 1999-05-13 BR BR9910401-6A patent/BR9910401A/en not_active Application Discontinuation
- 1999-05-13 PL PL99344573A patent/PL344573A1/en unknown
- 1999-05-13 CN CN99808325A patent/CN1308521A/en active Pending
- 1999-05-13 EP EP99922302A patent/EP1077682A2/en not_active Withdrawn
- 1999-05-13 AP APAP/P/2000/002019A patent/AP2000002019A0/en unknown
- 1999-05-13 WO PCT/GB1999/001520 patent/WO1999058113A2/en not_active Application Discontinuation
- 1999-05-13 EA EA200001174A patent/EA200001174A1/en unknown
- 1999-05-13 HU HU0102064A patent/HUP0102064A2/en unknown
- 1999-05-13 TR TR2000/03350T patent/TR200003350T2/en unknown
- 1999-05-13 SK SK1714-2000A patent/SK17142000A3/en unknown
- 1999-05-13 JP JP2000547965A patent/JP2002514591A/en active Pending
- 1999-05-13 IL IL13959499A patent/IL139594A0/en unknown
- 1999-05-13 AU AU39409/99A patent/AU3940999A/en not_active Abandoned
- 1999-05-13 ID IDW20002347A patent/ID28019A/en unknown
- 1999-05-13 KR KR1020007012706A patent/KR20010043574A/en not_active Application Discontinuation
-
2000
- 2000-11-10 NO NO20005683A patent/NO20005683L/en not_active Application Discontinuation
- 2000-11-13 ZA ZA200006562A patent/ZA200006562B/en unknown
- 2000-11-30 BG BG105010A patent/BG105010A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR9910401A (en) | 2001-01-09 |
NO20005683D0 (en) | 2000-11-10 |
CA2331871A1 (en) | 1999-11-18 |
AU3940999A (en) | 1999-11-29 |
CN1308521A (en) | 2001-08-15 |
WO1999058113A3 (en) | 2000-02-17 |
JP2002514591A (en) | 2002-05-21 |
IL139594A0 (en) | 2002-02-10 |
BG105010A (en) | 2001-07-31 |
NO20005683L (en) | 2000-12-05 |
EP1077682A2 (en) | 2001-02-28 |
PL344573A1 (en) | 2001-11-05 |
AP2000002019A0 (en) | 2000-12-31 |
HUP0102064A2 (en) | 2002-05-29 |
EA200001174A1 (en) | 2001-06-25 |
ZA200006562B (en) | 2002-02-13 |
WO1999058113A2 (en) | 1999-11-18 |
ID28019A (en) | 2001-05-03 |
KR20010043574A (en) | 2001-05-25 |
SK17142000A3 (en) | 2001-06-11 |
TR200003350T2 (en) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL343021A1 (en) | Formulations | |
GB9715751D0 (en) | Formulations | |
AP2000001874A0 (en) | Cellecoxib compositions | |
PL344327A1 (en) | Novel particulate formulations | |
PL341642A1 (en) | Novel macrolydes | |
EP1068213A4 (en) | Novel aminoorganofunctionalsiloxanes | |
IL139733A0 (en) | Novel compositions | |
GB9806312D0 (en) | Novel formulations | |
GB2339693B (en) | Anti-mollusc compositions | |
GB9805782D0 (en) | Compositions | |
GB9810180D0 (en) | Novel formulation | |
GB9806810D0 (en) | Compositions | |
GB9827291D0 (en) | Compositions | |
GB0016470D0 (en) | Compositions | |
GB9812818D0 (en) | Dentfrice compositions | |
GB9815002D0 (en) | Formulations | |
GB2336535B (en) | Compositions | |
GB9809347D0 (en) | Compositions | |
GB9815001D0 (en) | Formulations | |
GB9810181D0 (en) | Novel formulations | |
GB9605948D0 (en) | Novel formulations | |
GB9818905D0 (en) | Novel formulation | |
GB9818910D0 (en) | Novel formulation | |
GB9704521D0 (en) | Formulations | |
GB9703099D0 (en) | Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |